JAMES S J MANUSO
CIK 1236365 · President and CEO · last filed 2026-04-22
JAMES S J MANUSO is a President and CEO who has filed 53 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for OCUP, was dated Apr 22, 2026. Across all open-market trades the lifetime net is −$549.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $359.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$359.2K
4
53
-$549.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. (OCUP) Delisted | Director | 317,318 | $1.17 | $371.3K | $16.9K | 18 | 2026-04-22 |
| HURA | Director | — | $2.32 | — | $0 | 3 | 2026-02-17 |
| ASTX | Chief Executive Officer | 13,970 | $25.71 | $359.2K | -$571.3K | 8 | 2013-09-06 |
| Astex Pharmaceuticals, Inc (SUPG) Delisted | Chief Executive Officer | 3,470 | — | — | $4.6K | 16 | 2011-07-22 |
Recent Filings
53 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-22 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +24,367 | $0 | EDGAR |
| 2026-02-17 | HURA | Grant (A) | — | $0 | EDGAR |
| 2026-01-05 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +31,188 | $0 | EDGAR |
| 2025-05-02 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +79,504 | $0 | EDGAR |
| 2025-01-06 | HURA | Grant (A) | — | $0 | EDGAR |
| 2025-01-06 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +50,222 | $0 | EDGAR |
| 2024-10-22 | HURA | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +41,143 | $0 | EDGAR |
| 2024-01-03 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +22,090 | $0 | EDGAR |
| 2023-06-08 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +10,976 | $0 | EDGAR |